-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O2.6 617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Novel Molecular Markers for the Detection of Clonal Hematopoiesis and Minimal Residual Disease

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 9:30 AM-11:00 AM
W110, Level 1 (Orange County Convention Center)
Moderators:
Peter J M Valk, PhD, Erasmus University Medical Center, Erasmus MC Cancer Institute and Claudia Haferlach, MD, MLL Munich Leukemia Laboratory

Disclosures:
Haferlach: MLL Munich Leukemia Laboratory: Employment , Equity Ownership .
9:30 AM

Liran I. Shlush, MD PhD1, Amanda Mitchell, Ph.D.2*, Lawrence Heisler, Ph.D.3*, Sagi Abelson, Ph.D.2*, Monica Doedens1*, McLeod Jessica, Ms.C.2*, John D. McPherson, PhD4*, Thomas Hudson, M.D. Ph.D.3*, Jean C.Y. Wang, MD PhD5, Mark D. Minden, MD, PhD1 and John E. Dick, PhD1

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada
3Ontario Institute for Cancer Research, Toronto, ON, Canada
4Genome Technologies, Ontario Institute for Cancer Research, Toronto, ON, Canada
5Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

9:45 AM

Felicitas Thol, MD1, Larissa Köhler1*, Sabrina Klesse1*, Razif Gabdoulline1*, Arnold Kloos, PhD1*, Alessandro Liebich1*, Martin Wichmann2*, Anuhar Chaturvedi, PhD, MS, BPharm3*, Jana Fabisch1*, Verena I. Gaidzik, MD4*, Peter Paschka, MD4, Lars Bullinger, MD4, Gesine Bug, MD5*, Hubert Serve, MD6*, Gudrun Göhring, MD7*, Brigitte Schlegelberger, MD, PhD7, Michael Luebbert, MD8*, Hartmut H. Kirchner, MD9*, Mohammad Amen Wattad, MD10, Doris Kraemer, MD11*, Bernd Hertenstein, MD12*, Gerhard Heil, MD13*, Walter Fiedler, MD14, Juergen Krauter, MD15*, Richard F. Schlenk, MD16, Konstanze Döhner, MD4, Hartmut Döhner, MD4*, Arnold Ganser, M.D.1 and Michael Heuser, M.D.3

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannoverg, Germany
3Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
4Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
5Department of Medicine, Hematology/Oncology, University of Frankfurt, Frankfurt, Germany
6Dept. of Internal Medicine, University Hospital of Frankfurt, Frankfurt, Germany
7Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
8Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
9Klinikum Hannover Siloah, Hannover, Germany
10Kliniken Essen Sued, Essen, Germany
11Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany
12Klinikum Bremen Mitte, Bremen, Germany
13Department of Internal Medicine V, Klinikum Lüdenscheid, Lüdenscheid, Germany
14Department of Hematology and Oncology with sections Pneumonology and Bone Marrow Transplantation, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
15Department of Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany
16University Hospital of Ulm, Ulm, Germany

10:00 AM

Brian Parkin1, Angelina Londoño Joshi, PhD2*, Qing Kang, PhD1*, Andrew D. Rhim, MD2* and Sami N. Malek1

1Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
2Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI

10:15 AM

Verena I. Gaidzik, MD1*, Daniela Weber1*, Peter Paschka, MD1, Anna Kaumanns1*, Stefan Krieger1*, Andrea Corbacioglu, PhD1*, Jan Kroenke, MD1*, Silke Kapp-Schwoerer, MD1*, Doris Krämer, MD2*, Heinz A. Horst, MD, PhD3, Ingo Schmidt-Wolf, MD4, Gerhard Held, MD5*, Andrea Kuendgen, MD6*, Mark Ringhoffer, MD7*, Katharina Goetze, MD8*, Thomas Kindler, MD9*, Walter Fiedler, MD10, Mohammad Amen Wattad, MD11, Lars Bullinger, MD12, Brigitte Schlegelberger, MD, PhD13, Felicitas Thol, MD14, Michael Heuser, MD14, Arnold Ganser, M.D.14, Richard F. Schlenk, MD1, Hartmut Döhner, MD1* and Konstanze Döhner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Department of Oncology and Hematology, University of Oldenburg, Oldenburg, Germany
3Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
4Center for Integrated Oncology (CIO) and Medizinische Klinik und Poliklinik III, University of Bonn, Bonn, Germany
5Internal Medicine I, Saarland University Medical School, Homburg, Germany
6Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
7Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany
8Technische Universität München, München, Germany
9University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
10Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11Kliniken Essen Sued, Essen, Germany
12Department of Internal Medicine III, University of Ulm, Ulm, Germany
13Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
14Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

10:30 AM

Silke Kapp-Schwoerer, MD1*, Andrea Corbacioglu, PhD1*, Verena I. Gaidzik, MD1*, Peter Paschka, MD1, Daniela Weber1*, Jan Kroenke, MD1*, Maria-Veronica Teleanu, MD1*, Gudrun Göhring, MD2*, Brigitte Schlegelberger, MD, PhD2, Michael Luebbert, MD3*, Thomas Kindler, MD4*, Mohammad Amen Wattad, MD5, Andrea Kuendgen, MD6*, David Nachbaur, MD7*, Walter Fielder, MD8*, Helmut Rainer Salih9, Heinz A. Horst, MD, PhD10, Karin Tina Mayer, MD11*, Katharina S. Götze, MD12, Martin Bentz, MD13, Jan Schleicher, MD14*, Felicitas Thol, MD15, Michael Heuser, MD15, Jürgen Krauter, MD16*, Arnold Ganser, M.D.15, Richard F. Schlenk, MD1, Hartmut Döhner, MD1* and Konstanze Döhner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
3Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
4University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
5Department of Hematology, Oncology and Stem Cell Transplantation, Kliniken Essen Sued, Essen, Germany
6Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
7Department of Internal Medicine V, University Hospital Innsbruck, Innsbruck, Austria
8Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
9Department of Internal Medicine II, University Hospital of Tübingen, Tübingen, Germany
10Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
11Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany
12III. Department of Medicine, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany
13Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany
14Department of Hematology and Oncology, Katharinenhospital Stuttgart, Stuttgart, Germany
15Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
16Department of Internal Medicine III, Municipal Hospital of Braunschweig, Braunschweig, Germany

10:45 AM

Torsten Haferlach, Manja Meggendorfer, PhD*, Susanne Schnittger, PhD, Annette Fasan, PhD*, Wolfgang Kern, MD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

*signifies non-member of ASH